The cost of insurance cuts | Morning Newsletter
Philly patients worry about affording their weight-loss medications as some insurers tighten requirements around coverage.
Genmab A/S: Investigational Rinatabart Sesutecan (Rina-S) Continues to Show Encouraging Antitumor Activity in Patients with Advanced Ovarian Cancer
Media ReleaseCOPENHAGEN, Denmark; March 17, 2025 Results from Phase 2 RAINFOLTM-01 trial (B1 cohort) showed that with a median on-study follow-up of 48 weeks, Rina-S 120 mg/m2 led to a confirmed objec ...
Zenas BioPharma Appoints Lisa von Moltke, M.D., as Head of Research and Development and Chief Medical Officer
Dr. von Moltke brings over 30 years of deep drug development experience and a proven track record of clinical and regulatory success at both large and emerging global biopharmaceutical companies- ...
GB News on MSN7h
Release date confirmation gives Grand Theft Auto VI fans hope that rumoured delays are completely wrong
Rumours that Rockstar Games won't make its autumn deadline for the feverishly-anticipated Grand Theft Auto VI just won't go ...